Physician profile
Lance Braye
NPI 1215420195
$676.43
in general payments reported to CMS, 2019-2025
12 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $170 · 2023: $171 · 2024: $56.73 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $172.91 | 2022-2025 | Ozempic |
| Inspire Medical Systems, INC. | $138.63 | 2023 | Inspire |
| Lilly USA, LLC | $98.64 | 2022-2025 | Zepbound, Mounjaro |
| Gilead Sciences, INC. | $52.27 | 2025 | Epclusa |
| Xeris Pharmaceuticals, INC. | $45.91 | 2022 | |
| Abbvie INC. | $38.15 | 2022-2025 | |
| Medtronic, INC. | $32.11 | 2023 | Intellis Adaptivestim |
| Organon LLC | $22.88 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.83 | 2022 | |
| Dexcom, INC. | $18.19 | 2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.29 | 2022 | |
| Exact Sciences Corporation | $16.62 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Braye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.